PL2735316T3 - Nowe podejścia terapeutyczne do leczenia stanów zapalnych układu nerwowego - Google Patents

Nowe podejścia terapeutyczne do leczenia stanów zapalnych układu nerwowego

Info

Publication number
PL2735316T3
PL2735316T3 PL14156048T PL14156048T PL2735316T3 PL 2735316 T3 PL2735316 T3 PL 2735316T3 PL 14156048 T PL14156048 T PL 14156048T PL 14156048 T PL14156048 T PL 14156048T PL 2735316 T3 PL2735316 T3 PL 2735316T3
Authority
PL
Poland
Prior art keywords
new therapeutic
therapeutic approaches
neuroinflammatory conditions
treating neuroinflammatory
treating
Prior art date
Application number
PL14156048T
Other languages
English (en)
Inventor
Daniel Cohen
Serguei Nabirochkin
Ilya Chumakov
Original Assignee
Pharnext
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharnext filed Critical Pharnext
Publication of PL2735316T3 publication Critical patent/PL2735316T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14156048T 2009-03-30 2010-03-29 Nowe podejścia terapeutyczne do leczenia stanów zapalnych układu nerwowego PL2735316T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09305265A EP2236158A1 (en) 2009-03-30 2009-03-30 New therapeutic approaches for treating neuroinflammatory conditions
EP14156048.2A EP2735316B1 (en) 2009-03-30 2010-03-29 New therapeutic approaches for treating neuroinflammatory conditions

Publications (1)

Publication Number Publication Date
PL2735316T3 true PL2735316T3 (pl) 2017-06-30

Family

ID=41463183

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14156048T PL2735316T3 (pl) 2009-03-30 2010-03-29 Nowe podejścia terapeutyczne do leczenia stanów zapalnych układu nerwowego

Country Status (13)

Country Link
US (1) US8642566B2 (pl)
EP (3) EP2236158A1 (pl)
CY (1) CY1118455T1 (pl)
DK (1) DK2735316T3 (pl)
ES (2) ES2530847T3 (pl)
HR (1) HRP20161794T1 (pl)
HU (1) HUE032356T2 (pl)
LT (1) LT2735316T (pl)
PL (1) PL2735316T3 (pl)
PT (1) PT2735316T (pl)
SI (1) SI2735316T1 (pl)
SM (2) SMT201600479T1 (pl)
WO (1) WO2010115741A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2535046A1 (en) * 2011-06-17 2012-12-19 Institut Pasteur Use of mecamylamine in the treatment of pathogen-infected patients with central nervous system disorder
WO2015051152A1 (en) * 2013-10-03 2015-04-09 Leuvas Therapeutics Modulation of leukocyte activity in treatment of neuroinflammatory degenerative disease
KR101809379B1 (ko) * 2016-10-13 2017-12-14 연세대학교 산학협력단 디오스민 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물
JP7588859B2 (ja) * 2019-04-18 2024-11-25 ユニベルシテ・ド・リエージュ グラム陰性細菌の感染、汚染、及びファウリングを予防及び治療するための新規ピリミジン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition

Also Published As

Publication number Publication date
PT2735316T (pt) 2017-01-10
SMT201600479B (it) 2017-03-08
SMT201600479T1 (it) 2017-03-08
SI2735316T1 (sl) 2017-05-31
HRP20161794T1 (hr) 2017-03-10
EP2236158A1 (en) 2010-10-06
ES2530847T3 (es) 2015-03-06
US20120108528A1 (en) 2012-05-03
EP2413970A2 (en) 2012-02-08
HUE032356T2 (en) 2017-09-28
DK2735316T3 (en) 2017-01-23
EP2735316B1 (en) 2016-10-05
ES2609962T3 (es) 2017-04-25
US8642566B2 (en) 2014-02-04
EP2413970B1 (en) 2015-01-07
LT2735316T (lt) 2017-04-10
EP2735316A1 (en) 2014-05-28
CY1118455T1 (el) 2017-07-12
WO2010115741A3 (en) 2010-12-02
WO2010115741A2 (en) 2010-10-14

Similar Documents

Publication Publication Date Title
IL214919A0 (en) Method for therapeutic use
IL219412A0 (en) New therapeutic approaches for treating alzheimer disease
IL216013A (en) Dermatologic Treatment Devices
IL224771A (en) Skin Care Device
PL2558105T3 (pl) Metylowany bardoksolon do leczenia otyłości
IL212793A0 (en) Handpiece for treating skin
IL215975A (en) Heart failure device
IL218633A0 (en) Methods for treating psoriasis
IL218283A0 (en) Combination therapy for treating proliferative diseases
EP2621498A4 (en) COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
ZA201204845B (en) Agents for treating disease
EP2453748A4 (en) METHOD OF TREATMENT
EP2453896A4 (en) PROCESS FOR TREATING SCHIZOPHRENIA
GB0900599D0 (en) Treatment
SI2735316T1 (sl) Novi terapevtski pristopi za zdravljenje nevroinflamatornih stanj
IL213287A0 (en) Treatment for glomerulonephritis
GB0913968D0 (en) Treatment
EP2240192A4 (en) TREATMENT OF DERMATOLOGICAL SUFFERING
ZA201202379B (en) Antagonists of dsgs2 for treatment of cancer
PL2391366T3 (pl) Podstawione benzimidazole do leczenia gwiaździaków
GB201001521D0 (en) Treatment
ZA201201894B (en) Pharmaceutical combination for treating tumor
GB0906026D0 (en) Therapeutic compounds
GB0913427D0 (en) Compounds for treatment of imflammation
GB0900712D0 (en) Therapeutic compounds